McKesson gets US go-ahead to buy US Oncology

* Deal helps McKesson move into high-margin oncology space

* FTC announces deal approval

WASHINGTON, Dec 21 (BestGrowthStock) – Pharmaceutical distributor
McKesson Corp (MCK.N: ) has won U.S. antitrust approval to buy
privately held US Oncology Inc, the Federal Trade Commission
said on Tuesday.

McKesson valued the deal at $2.16 billion when it announced
the purchase on Nov. 1, but said this included assumption of
outstanding debt of about $1.6 billion. The acquisition will
help McKesson expand its services in the fast-growing area of
cancer care.

The approval was announced in a list that the FTC puts out
several times a week.

The deal would give McKesson a 25 percent share of the
specialty distribution market and a significant exposure to the
lucrative and fast-growing high-margin oncology space, analysts
said.
(Reporting by Diane Bartz, editing by Dave Zimmerman)

McKesson gets US go-ahead to buy US Oncology